The University of Southampton
University of Southampton Institutional Repository
Warning ePrints Soton is experiencing an issue with some file downloads not being available. We are working hard to fix this. Please bear with us.

The Impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent

The Impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent
The Impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent
The effect of Uterine Fibroid Embolization on fertility and ovarian reserve remains uncertain. We assessed the impact of a new resorbable, spherical particle (Gelbead) on concentration of Anti-Mullerian (AMH) hormone, fibroid volume and uterine artery patency. This prospective cohort study recruited consecutive patients from July 2017 to June 2018. Serum AMH, fibroid and uterine volume, UFS-QOL (uterine fibroid score-quality of life) scores were measured prior to and at 1 month and/or 3 months post embolization. Twenty-four participants were enrolled (median age 44 years, uterine volume 484 cm3, initial dominant fibroid volume 167 cm3). One patient was lost to follow-up. AMH (median ± SD) immediately prior to embolization was 3.2 ± 13.7 pmol/L. At 1-month postembolization, AMH was 4.1 ± 8.6 pmol/L and at 3 months 4.4 ± 8.6 pmol/L. We found no significant difference in AMH levels between baseline and at 1 month (p = 0.58) or baseline and 3 months (p = 0.17). The median dominant uterine fibroid volume decreased (167 to 64 cm3, p < 0.001). At 3 months post-embolization, 17/23 patients had patent uterine arteries bilaterally (73.9%). UFE with Gel-bead did not significantly affect AMH at 3 months post embolization, whilst maintaining a high rate of uterine artery patency.
embolization, fertility, fibroid, resorbable, uterine
1464-7273
Hacking, Nigel
b6287f0b-1b80-49a6-a01a-f52f9da671c8
Vigneswaran, Ganesh
4e3865ad-1a15-4a27-b810-55348e7baceb
Maclean, Drew
9a01537b-1471-4ea2-9273-23f4a86157b0
Bryant, Timothy
b4eaf822-702a-40a6-990b-f178d751f7a9
Umranikar, Sameer
293e009a-22bd-4b62-8680-def7d7d361fb
Cheong, Ying
4efbba2a-3036-4dce-82f1-8b4017952c83
Modi, Sachin
1507f4a2-9733-4441-823a-666bb852e0f3
Hacking, Nigel
b6287f0b-1b80-49a6-a01a-f52f9da671c8
Vigneswaran, Ganesh
4e3865ad-1a15-4a27-b810-55348e7baceb
Maclean, Drew
9a01537b-1471-4ea2-9273-23f4a86157b0
Bryant, Timothy
b4eaf822-702a-40a6-990b-f178d751f7a9
Umranikar, Sameer
293e009a-22bd-4b62-8680-def7d7d361fb
Cheong, Ying
4efbba2a-3036-4dce-82f1-8b4017952c83
Modi, Sachin
1507f4a2-9733-4441-823a-666bb852e0f3

Hacking, Nigel, Vigneswaran, Ganesh, Maclean, Drew, Bryant, Timothy, Umranikar, Sameer, Cheong, Ying and Modi, Sachin (2021) The Impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent. Human Fertility. (doi:10.1080/14647273.2021.1920055).

Record type: Article

Abstract

The effect of Uterine Fibroid Embolization on fertility and ovarian reserve remains uncertain. We assessed the impact of a new resorbable, spherical particle (Gelbead) on concentration of Anti-Mullerian (AMH) hormone, fibroid volume and uterine artery patency. This prospective cohort study recruited consecutive patients from July 2017 to June 2018. Serum AMH, fibroid and uterine volume, UFS-QOL (uterine fibroid score-quality of life) scores were measured prior to and at 1 month and/or 3 months post embolization. Twenty-four participants were enrolled (median age 44 years, uterine volume 484 cm3, initial dominant fibroid volume 167 cm3). One patient was lost to follow-up. AMH (median ± SD) immediately prior to embolization was 3.2 ± 13.7 pmol/L. At 1-month postembolization, AMH was 4.1 ± 8.6 pmol/L and at 3 months 4.4 ± 8.6 pmol/L. We found no significant difference in AMH levels between baseline and at 1 month (p = 0.58) or baseline and 3 months (p = 0.17). The median dominant uterine fibroid volume decreased (167 to 64 cm3, p < 0.001). At 3 months post-embolization, 17/23 patients had patent uterine arteries bilaterally (73.9%). UFE with Gel-bead did not significantly affect AMH at 3 months post embolization, whilst maintaining a high rate of uterine artery patency.

Text
Human_Fertility_AMH_revised - Accepted Manuscript
Restricted to Repository staff only until 30 April 2022.
Request a copy
Text
Human_Fertility_AMH_revised
Restricted to Repository staff only
Request a copy
Text
Tables_AMH
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 28 February 2021
e-pub ahead of print date: 30 April 2021
Additional Information: Attention. Embargo as per journal specifics please
Keywords: embolization, fertility, fibroid, resorbable, uterine

Identifiers

Local EPrints ID: 449359
URI: http://eprints.soton.ac.uk/id/eprint/449359
ISSN: 1464-7273
PURE UUID: 6c04ae8a-5dda-47f3-ba40-ccb4a2d5cdba
ORCID for Ganesh Vigneswaran: ORCID iD orcid.org/0000-0002-4115-428X
ORCID for Ying Cheong: ORCID iD orcid.org/0000-0001-7687-4597

Catalogue record

Date deposited: 26 May 2021 16:30
Last modified: 26 Nov 2021 03:24

Export record

Altmetrics

Contributors

Author: Nigel Hacking
Author: Drew Maclean
Author: Timothy Bryant
Author: Sameer Umranikar
Author: Ying Cheong ORCID iD
Author: Sachin Modi

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×